Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Newton Biocapital

Founders Alain Parthoens

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 19
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 13
Rounds per year 3.17
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.32
Exits 2
Key employees 7
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Medical
  • Medical Device
  • Health Care
  • Pharmaceutical
Summary

In 2017 was created Newton Biocapital, which is appeared as VC. The main office of represented VC is situated in the Brussels. The fund was located in Europe if to be more exact in Belgium.

The current fund was established by Alain Parthoens. The overall number of key employees were 7.

This Newton Biocapital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium. Among the various public portfolio startups of the fund, we may underline DIM3, Synergia Medical, ChromaCure The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Project Management, Manufacturing.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Newton Biocapital, startups are often financed by VI Partners AG, Neomed Management, Entrepreneurs Fund. The meaningful sponsors for the fund in investment in the same round are S.R.I.W., SFPI-FPIM, CapDecisif. In the next rounds fund is usually obtained by Go Capital, CapDecisif, Anaxago.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Newton Biocapital:
Typical Co-investors
Newton Biocapital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Newton Biocapital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Belgium
Funds with similar focus located in Belgium:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BBVA Panamá, Panama, Panama City
BLC Bank Beirut, Beyrouth, Lebanon
Clear Ventures California, Palo Alto, United States
Cornel Capital Partners Chicago, Illinois, United States
DKR Capital Connecticut, Stamford, United States
Evergrande Health Industry Group China, Guangdong, Guangzhou
Grand Sud Ouest Capital Aquitaine, Bordeaux, France
Halton Kentucky, Scottsville, United States
Highway 12 Ventures Boise, Idaho, United States
Integrale Advisors California, Sunnyvale, United States
Ningo Meishan Baoshui Gangqu Yunwanxingtong Investment Management China, Ningbo, Zhejiang
Pomona Impact -
Sazze Partners California, San Jose, United States
Shidu Zichan Beijing, China, Haidian
SLD Entertainment Japan, Minato
Startupbootcamp InsurTech London England, London, United Kingdom
Umusun Lab Japan, Okinawa, Okinawa Prefecture
Universal Materials Incubator Japan, Tokyo
Uphold California, San Francisco, United States
Yuxin Jiuding (Xiamen) Touzi Guanli Zhongxin -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

AbolerIS Pharma

Biotechnology
$32M19 Sep 2023 Nantes, Pays de la Loire, France

Santero Therapeutics

Biotechnology
Health Care
Therapeutics
$9M08 Jun 2023 Charleroi, Hainaut, Belgium

AdipoPharma

Biotechnology
Medical
Pharmaceutical
23 Jan 2023 Illkirch-graffenstaden, Alsace, France

DeuterOncology

Biotechnology
Medical
$6M19 Jan 2023 Belgium, Antwerp, Belgium

NeuVasQ

Medical
Pharmaceutical
$23M24 Jun 2021 Gosselies, Hainaut, Belgium

DeuterOncology

Biotechnology
Medical
24 Feb 2021 Belgium, Antwerp, Belgium

AbolerIS Pharma

Biotechnology
$2M04 Nov 2020 Nantes, Pays de la Loire, France

Acticor Biotech

Biopharma
Biotechnology
Pharmaceutical
Therapeutics
$8M06 Nov 2019 France, Ile-de-France

EditForce

Biotechnology
$7M01 Mar 2019 Fukuoka, Fukuoka Prefecture, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Newton Biocapital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 19
Average round size 8M
Rounds per year 3.17
Peak activity year 2018
Lead investments 4
Follow on index 0.32
Exits 2
Group Appearance index 0.84

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

AbolerIS Pharma

Biotechnology
$32M19 Sep 2023 Nantes, Pays de la Loire, France

Santero Therapeutics

Biotechnology
Health Care
Therapeutics
$9M08 Jun 2023 Charleroi, Hainaut, Belgium

AdipoPharma

Biotechnology
Medical
Pharmaceutical
23 Jan 2023 Illkirch-graffenstaden, Alsace, France

DeuterOncology

Biotechnology
Medical
$6M19 Jan 2023 Belgium, Antwerp, Belgium

NeuVasQ

Medical
Pharmaceutical
$23M24 Jun 2021 Gosselies, Hainaut, Belgium

DeuterOncology

Biotechnology
Medical
24 Feb 2021 Belgium, Antwerp, Belgium

AbolerIS Pharma

Biotechnology
$2M04 Nov 2020 Nantes, Pays de la Loire, France

Acticor Biotech

Biopharma
Biotechnology
Pharmaceutical
Therapeutics
$8M06 Nov 2019 France, Ile-de-France

EditForce

Biotechnology
$7M01 Mar 2019 Fukuoka, Fukuoka Prefecture, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: